Quality Chemical Industries Limited's latest marketcap:
As of 07/05/2025, Quality Chemical Industries Limited's market capitalization has reached $90.36 M. According to our data, Quality Chemical Industries Limited is the 25383th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 90.36 M |
| Revenue (ttm) | 74.26 M |
| Net Income (ttm) | 11.3 M |
| Shares Out | 3.65 B |
| EPS (ttm) | 0 |
| Forward PE | 0.00 |
| Ex-Dividend Date | 08/05/2025 |
| Earnings Date | 06/16/2025 |
Quality Chemical Industries Limited's yearly market capitalization.
| Date | Market Cap(UGX) | Change (%) | Global Rank |
|---|---|---|---|
| 07/05/2025 | 90.36 M | 40.16% | 25383 |
| 12/31/2024 | 231.9 B | 20.95% | 26411 |
| 12/29/2023 | 191.73 B | -12.5% | 27776 |
| 12/30/2022 | 219.11 B | -34.78% | 25752 |
| 12/30/2021 | 335.98 B | -10.68% | 23509 |
| 12/31/2020 | 376.15 B | 0.98% | 20523 |
| 12/31/2019 | 372.49 B | -46.32% | 18094 |
| 12/31/2018 | 693.86 B | 14243 |
Company Profile
About Quality Chemical Industries Limited
Quality Chemical Industries Limited is a leading pharmaceutical manufacturer based in Kampala, Uganda. Established in 2005, the company specializes in producing treatments for critical diseases such as HIV/AIDS, Malaria, Hepatitis, and Tuberculosis, among others.
Key Products & Treatments
- HIV/AIDS: Lamivudine/Tenofovir Disoproxil Fumarate, Dolutegravir, Efavirenz, and Zidovudine tablets.
- Malaria: Lumartem/Lumet tablets.
- Hepatitis B: Texavir and Zentair.
- Tuberculosis: Isoniazid/Pyridoxine Hydrochloride/Sulfamethoxazole Trimethoprim tablets.
- Other Treatments:
- Emeset (nausea & vomiting).
- Ciplox & Azicip (anti-infectives).
- Amlopres (hypertension).
- Erecto (reproductive disorders).
Global Reach & Corporate Information
The company exports its pharmaceutical products to 13 African countries, ensuring widespread access to essential medicines. Formerly known as Cipla Quality Chemical Industries Limited, the company rebranded to its current name in February 2024.
Parent Company: Quality Chemical Industries Limited operates as a subsidiary of Cipla Limited.
Frequently Asked Questions
-
What is Quality Chemical Industries Limited's (UGSE-QCIL) current market cap?As of 07/05/2025, Quality Chemical Industries Limited (including the parent company, if applicable) has an estimated market capitalization of $90.36 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Quality Chemical Industries Limited (UGSE-QCIL) rank globally by market cap?Quality Chemical Industries Limited global market capitalization ranking is approximately 25383 as of 07/05/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.